Abstract
The paper reports the results of a study to assess the contraceptive efficacy of a new triphasic pill (Trinovum - Cilag AG). The pill was administered to 50 women aged between 18 and 41 years for 12 months, giving a total of 600 menstrual cycles. Data confirm the value of this pill which ensures excellent contraceptive efficacy and is well tolerated by patients with very few adverse effects.
MeSH terms
-
Adolescent
-
Adult
-
Contraceptives, Oral, Combined / administration & dosage*
-
Contraceptives, Oral, Combined / pharmacology
-
Drug Combinations
-
Drug Evaluation
-
Ethinyl Estradiol / administration & dosage*
-
Ethinyl Estradiol / pharmacology
-
Female
-
Humans
-
Norethindrone / administration & dosage*
-
Norethindrone / pharmacology
-
Progestins / administration & dosage
-
Progestins / pharmacology
Substances
-
Contraceptives, Oral, Combined
-
Drug Combinations
-
Progestins
-
norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination
-
Ethinyl Estradiol
-
Norethindrone